In HER2-positive tumours, early postcontrast T1 enhancement and low T2 signal were linked to proliferation and immune-related gene expression (MLKL, CXCL10), suggesting high angiogenesis, cellularity, and immune infiltration. Here, ERBB2 is linked to neoplasm.